Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole for Multi-Drug Resistant Pulmonary Tuberculosis
NCT00425113Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2006
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metronidazole in Tuberculosis (TB), sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 2006; status: completed.
02
Drugs
metronidazole
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00425113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425113.